PF-05402536

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NamePF-05402536

Drug Alias NamePF-5402536PF-05402536

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Biological material > Toxoid vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsSmoking CessationInfluenza B virus infection

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsSmoking CessationInfluenza B virus infection

ATC CodeN/A